Selective targeting of neuroblastoma tumour‐initiating cells by compounds identified in stem cell‐based small molecule screens
Open Access
- 18 August 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in EMBO Molecular Medicine
- Vol. 2 (9), 371-384
- https://doi.org/10.1002/emmm.201000093
Abstract
Neuroblastoma (NB) is the most deadly extra‐cranial solid tumour in children necessitating an urgent need for effective and less toxic treatments. One reason for the lack of efficacious treatments may be the inability of existing drugs to target the tumour‐initiating or cancer stem cell population responsible for sustaining tumour growth, metastases and relapse. Here, we describe a strategy to identify compounds that selectively target patient‐derived cancer stem cell‐like tumour‐initiating cells (TICs) while sparing normal paediatric stem cells (skin‐derived precursors, SKPs) and characterize two therapeutic candidates. DECA‐14 and rapamycin were identified as NB TIC‐selective agents. Both compounds induced TIC death at nanomolar concentrations in vitro, significantly reduced NB xenograft tumour weight in vivo, and dramatically decreased self‐renewal or tumour‐initiation capacity in treated tumours. These results demonstrate that differential drug sensitivities between TICs and normal paediatric stem cells can be exploited to identify novel, patient‐specific and potentially less toxic therapies.Keywords
This publication has 47 references indexed in Scilit:
- The therapeutic promise of the cancer stem cell conceptJCI Insight, 2010
- SKPs Derive from Hair Follicle Precursors and Exhibit Properties of Adult Dermal Stem CellsCell Stem Cell, 2009
- Long-term Outcomes in Survivors of Neuroblastoma: A Report From the Childhood Cancer Survivor StudyJNCI Journal of the National Cancer Institute, 2009
- Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancerJCI Insight, 2008
- The third dimension bridges the gap between cell culture and live tissueNature Reviews Molecular Cell Biology, 2007
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray ExperimentsStatistical Applications in Genetics and Molecular Biology, 2004
- Improved Statistical Methods for Hit Selection in High-Throughput ScreeningSLAS Discovery, 2003
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Inhibition and photoinactivation of the bovine heart mitochondrial F1-ATPase by the cytotoxic agent, dequaliniumBiochemical and Biophysical Research Communications, 1988
- Selective antimitochondrial agents inhibit calmodulinBiochemical and Biophysical Research Communications, 1986